Professor Poul Nissen and his research team with contributions from e.g. Kurt Gothelf's laboratories have provided fundamental new insight into the mechanism of the medical drug dimethyl fumarate, which is the active component of important treatments for multiple sclerosis and psoriasis. The results contribute to the development of new strategies for drug discovery.